Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-09 03:19 | 2025-07-03 | IRON | Disc Medicine, Inc. | Quisel John D | Director, Officer | OPT+S | $55.09 | 5,200 | $286,454 | 161,828 |
| 2025-07-08 23:05 | 2025-07-03 | RCKT | ROCKET PHARMACEUTICALS, INC. | Ondrey Aaron | Officer | SELL | $2.88 | 1,477 | $4,257 | 128,173 |
| 2025-07-08 23:21 | 2025-07-08 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | Officer | OPT+S | $33.76 | 2,000 | $67,520 | 140,610 |
| 2025-07-07 15:52 | 2025-07-02 | IMRX | Immuneering Corp | Neufeld Leah R | Officer | BUY | $3.57 | 700 | $2,499 | 10,729 |
| 2025-07-07 23:03 | 2025-07-03 | MLTX | MoonLake Immunotherapeutics | Moukheibir Catherine | Director | OPT+S | $48.79 | 23,500 | $1,146,565 | 0 |
| 2025-07-08 00:20 | 2025-07-02 | BCYC | BICYCLE THERAPEUTICS PLC | Lee Kevin | Director, Officer | SELL | $7.29 | 5,461 | $39,836 | 480,804 |
| 2025-07-08 00:20 | 2025-07-02 | BCYC | BICYCLE THERAPEUTICS PLC | Skynner Michael | Officer | SELL | $7.28 | 1,791 | $13,036 | 120,079 |
| 2025-07-08 00:20 | 2025-07-02 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | Officer | SELL | $7.25 | 2,115 | $15,334 | 95,502 |
| 2025-07-08 00:20 | 2025-07-02 | BCYC | BICYCLE THERAPEUTICS PLC | Hannay Michael Charles Ferguson | Officer | SELL | $7.21 | 722 | $5,206 | 53,825 |
| 2025-07-08 00:20 | 2025-07-02 | BCYC | BICYCLE THERAPEUTICS PLC | Thompson Travis Alvin | Officer | SELL | $7.20 | 306 | $2,205 | 31,521 |
| 2025-07-08 00:20 | 2025-07-02 | BCYC | BICYCLE THERAPEUTICS PLC | Young Alethia | Officer | SELL | $7.09 | 204 | $1,446 | 45,186 |
| 2025-07-07 15:59 | 2025-07-02 | IMRX | Immuneering Corp | HAUSMAN DIANA | Director | BUY | $3.61 | 5,500 | $19,863 | 3,000 |
| 2025-07-04 02:39 | 2025-07-01 | LFVN | Lifevantage Corp | Aure Carl | Officer | OPT+S | $13.39 | 2,746 | $36,769 | 133,303 |
| 2025-07-03 21:55 | 2025-07-01 | TERN | Terns Pharmaceuticals, Inc. | Kuriakose Emil | Officer | SELL | $4.27 | 853 | $3,640 | 52,464 |
| 2025-07-03 23:15 | 2025-07-01 | BRFG | BullFrog AI Holdings, Inc. | Singh Vininder | Director, Officer, 10% owner | SELL | $1.57 | 20,998 | $32,910 | 2,321,448 |
| 2025-07-03 16:12 | 2025-07-01 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Director, Officer, 10% owner | BUY | $3.49 | 10,000 | $34,879 | 2,312,852 |
| 2025-07-04 01:48 | 2025-07-02 | MIRM | Mirum Pharmaceuticals, Inc. | Howe Jolanda | Officer | OPT+S | $48.63 | 1,041 | $50,624 | 2,426 |
| 2025-07-04 01:00 | 2025-07-01 | AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Officer | SELL | $52.88 | 2,000 | $105,760 | 29,891 |
| 2025-07-03 23:30 | 2025-07-01 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Director, Officer | SELL | $42.63 | 80,000 | $3,410,448 | 955,686 |
| 2025-07-03 23:07 | 2025-07-02 | ZLAB | Zai Lab Ltd | Du Ying | Director, Officer | OPT+S | $35.23 | 7,072 | $249,147 | 536,962 |
| 2025-07-04 02:50 | 2025-07-01 | PMVP | PMV Pharmaceuticals, Inc. | Jalota Deepika | Officer | SELL | $1.06 | 33,065 | $35,198 | 89,959 |
| 2025-07-04 02:49 | 2025-07-01 | PMVP | PMV Pharmaceuticals, Inc. | Carulli Michael | Officer | SELL | $1.06 | 28,249 | $30,077 | 60,146 |
| 2025-07-04 03:56 | 2025-07-01 | JUNS | JUPITER NEUROSCIENCES, INC. | Silva Alison D. | Director, Officer | BUY | $1.03 | 750 | $772 | 112,777 |
| 2025-07-03 21:53 | 2025-07-01 | JUNS | JUPITER NEUROSCIENCES, INC. | ROSEN CHRISTER | Director, Officer, 10% owner | BUY | $1.02 | 3,600 | $3,667 | 11,078,892 |
| 2025-07-03 23:21 | 2025-07-01 | SPRY | ARS Pharmaceuticals, Inc. | Karas Eric | Officer | OPT+S | $16.99 | 15,000 | $254,861 | 10,315 |
| 2025-07-04 00:12 | 2025-07-02 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Garfield Alastair | Officer | OPT+S | $64.81 | 1,319 | $85,483 | 3,126 |
| 2025-07-03 23:15 | 2025-07-02 | KZR | Kezar Life Sciences, Inc. | Chiang Pichi Luo | Officer | SELL | $4.28 | 264 | $1,130 | 2,711 |
| 2025-07-03 23:15 | 2025-07-02 | KZR | Kezar Life Sciences, Inc. | Schiller Mark C. | Officer | SELL | $4.28 | 561 | $2,401 | 2,739 |
| 2025-07-04 02:51 | 2025-07-01 | PMVP | PMV Pharmaceuticals, Inc. | Ticktin Robert | Officer | SELL | $1.06 | 23,151 | $24,651 | 98,695 |
| 2025-07-03 22:31 | 2025-07-03 | VKTX | Viking Therapeutics, Inc. | Lian Brian | Director, Officer | SELL | $27.80 | 26,889 | $747,633 | 2,388,014 |
| 2025-07-03 22:30 | 2025-07-03 | VKTX | Viking Therapeutics, Inc. | Mancini Marianna | Officer | SELL | $27.77 | 4,266 | $118,473 | 377,535 |
| 2025-07-03 23:41 | 2025-07-01 | SLNO | SOLENO THERAPEUTICS INC | Hirano Patricia C | Officer | SELL | $82.76 | 3,830 | $316,971 | 13,206 |
| 2025-07-03 23:01 | 2025-07-01 | AGIO | Agios Pharmaceuticals Inc. | Gheuens Sarah | Officer | OPT+S | $34.17 | 4,091 | $139,789 | 61,271 |
| 2025-07-04 02:48 | 2025-07-01 | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Director, Officer | SELL | $1.06 | 58,411 | $62,179 | 536,133 |
| 2025-07-04 00:30 | 2025-07-02 | AMPH | Amphastar Pharmaceuticals Inc. | Petersen Floyd F. | Director | SELL | $23.47 | 500 | $11,734 | 77,531 |
| 2025-07-03 15:01 | 2025-07-02 | CLRB | Cellectar Biosciences, Inc. | Longcor Jarrod | Officer | BUY | $4.99 | 10,000 | $49,900 | 12,768 |
| 2025-07-03 15:00 | 2025-07-02 | CLRB | Cellectar Biosciences, Inc. | Kolean Chad J | Officer | BUY | $4.99 | 5,000 | $24,950 | 6,418 |
| 2025-07-03 22:31 | 2025-07-03 | VKTX | Viking Therapeutics, Inc. | ZANTE GREG | Officer | SELL | $27.76 | 4,266 | $118,428 | 168,660 |
| 2025-07-03 15:02 | 2025-07-02 | CLRB | Cellectar Biosciences, Inc. | CARUSO JAMES V | Director, Officer | BUY | $4.99 | 10,000 | $49,900 | 11,638 |
| 2025-07-03 21:56 | 2025-07-01 | JAZZ | Jazz Pharmaceuticals plc | COZADD BRUCE C | Director, Officer | SELL | $107.63 | 1,000 | $107,630 | 436,973 |
| 2025-07-03 20:34 | 2025-07-02 | ANAB | AnaptysBio Inc. | RENTON HOLLINGS | Director | OPT+S | $23.57 | 20,925 | $493,190 | 4,965 |
| 2025-07-03 20:09 | 2025-07-02 | BSPK | Bespoke Extracts, Inc. | FEINSOD MICHAEL | Director, Officer, 10% owner | BUY | $0.11 | 8,000 | $880 | 2,503,412 |
| 2025-07-04 03:39 | 2025-07-01 | CORT | CORCEPT THERAPEUTICS INC | Guyer William | Officer | OPT+S | $73.51 | 100 | $7,351 | 5,487 |
| 2025-07-04 03:36 | 2025-07-01 | CORT | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas | Officer | OPT+S | $73.51 | 100 | $7,351 | 10,066 |
| 2025-07-04 03:35 | 2025-07-01 | CORT | CORCEPT THERAPEUTICS INC | Maduck Sean | Officer | OPT+S | $73.45 | 205 | $15,058 | 17,705 |
| 2025-07-02 23:30 | 2025-06-30 | XOMA | XOMA Royalty Corp | Sitko Bradley | Officer | BUY | $25.39 | 2,000 | $50,780 | 7,045 |
| 2025-07-02 23:25 | 2025-07-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | SELL | $13.84 | 9,208 | $127,430 | 100,206 |
| 2025-07-02 23:07 | 2025-07-01 | ORIC | Oric Pharmaceuticals, Inc. | Piscitelli Dominic | Officer | SELL | $10.05 | 20,000 | $200,972 | 48,317 |
| 2025-07-02 23:09 | 2025-07-01 | STOK | Stoke Therapeutics, Inc. | Ticho Barry | Officer | SELL | $11.63 | 4,503 | $52,379 | 21,279 |
| 2025-07-03 03:47 | 2025-07-02 | ETST | Earth Science Tech, Inc. | Sanchez Yovan Arturo | Director | BUY | $0.20 | 60,805 | $12,161 | 1,666,956 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.